Daewon Pharmaceutical Co., Ltd. (KOSE:A003220) agreed to acquire 83.5% stake in Keukdong H-Pharm Co., Ltd. for KRW 14.1 billion on May 12, 2021. The buyer will purchase 59,793 shares of Keukdong H-Pharm and the purchase will through cash. For the year ended 2020, total assets of Keukdong H-Pharm recorded KRW 28.8 billion, revenue of KRW 23.5 billion, net loss of KRW 2.6 billion, and is total equity of KRW 1.8 billion. The Board of buyer passes the resolution on the transaction on May 12, 2021. The transaction is expected to close on May 26, 2021.